If you encounter issues logging in with your credentials, please contact our customer services team and we will endeavour to assist as quickly as possible Sponsor deploys Permira VIII to ride new wave ...

The GP will acquire a 66% stake in the company via its €250m KJK Fund III, which held a final close in January 2020 and is focused on SMEs in the Balkan and Baltic regions. Gediminas Šimkus, the ...

The Luxembourg filing was made earlier in August 2022. Montagu declined to comment. The GP held a final close for its predecessor vehicle, Montagu VI, in 2020 on EUR 3.3bn, surpassing its EUR 3bn ...

The transaction remains subject to approval from the Dutch healthcare and competition authorities. The company's management team will continue to lead the business, the GP said in a statement. NPM ...

The business, which provides wastewater services and products, is expected to be marketed off annual EBITDA in the region of USD 20m, according to one of the sources and a third familiar with the ...

Initial bids for the business were due last week, said one of the sources. Permira already owns Neuraxpharm, a specialty pharma company focused on the treatment of the central nervous system (CNS), ...

NPM is acquiring the stake from Ploeger Oxbo. Existing shareholders of the company are three Dutch investment companies Synergia Capital Partners, VDL Participatie and Bolster Investment Partners, all ...

Y1 owns a portfolio of healthcare services businesses in the UK and Europe, including cosmetic surgery and hair transplant chain Signature Medical. The buying GP's CEO Tony Veverka is the former CEO ...

The deal is reportedly worth around €2.5bn, equal to approximately 18x Galileo's EBITDA. CPP invested through its wholly owned subsidiary CPP Investment Board Europe. The consortium also comprises ...

TA XV closed on its hard cap, exceeding its initial target size, after launching in November 2022. Few sponsors, especially generalist buyout funds, have been able to close multi-billion funds in the ...

DIF Core Infrastructure Fund I closed on €450m in 2017. The two firms will wholly acquire the company, each taking a 50% stake for an undisclosed sum. The firms have agreed to back Unitank's long-term ...

The deal values the company at around £300m. A source close to the situation told Unquote the firm generated a 6.6x return. SpaMedica is to be merged with Ober Scharrer Group, a Germany-based ...